Search clinical trials for: Clofazimine Oral Product
Total 0 results
Nothing found
Sponsors and Collaborators
- Diego Hernan Giunta, MD
- Fondren Orthopedic Group L.L.P.
- Victor Montori
- Rui-hua Xu, MD, PhD
- Norsk Proteinintolerance, Norway
- Alberta Children's Hospital, Calgary, Canada
- Celtaxsys Aus Pty Limited
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Caritas Freetown
- San MediTech(Huzhou)Co.,Ltd.
- Societa Italiana di Endoscopia Digestiva
- Elim Pediatric Pharmaceuticals Inc.
- University Medical Center Goettingen
- Cardresearch
- ProteoSys AG
- CRMBM-CEMEREM
- Donders Institute for Brain, Cognition and Behavior
- AMTC & Associates
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- The Fifth Affiliated Hospital of Zunyi Medical College
- View Full List
Medical Conditions
- Prostate Cancer Recurrent
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Spermatogenesis Arrest
- Lymphedema of Arm
- Non-compressible Torso Hemorrhage
- Disturbance of Activity and Attention
- Non-dystrophic Myotonias
- Fever, Sweats, and Hot Flashes
- Tube Disorders Eustachian
- Tularaemia
- Normal Diameter of Optic Nerve
- Atrial Fibrillation, Postoperative
- Postcomatose Unawareness State
- Orbital Tumor
- Auditory Hallucination, Verbal
- Malignant Ascites Due to Epithelial Carcinoma
- Plasmodium Falciparum Malaria (Drug Resistant)
- Stereotactic Radioablation for Ventricular Tachycardia
- Gynecologic Cancer
- Fibromyalgia Syndrome, Primary
- View Full List
Drug Interventions
- Cetrorelix 78 mg + 78 mg
- Insulin
- Topotecan
- Epimedium Prenylflavonoids Extract
- Mupirocin Calcium
- Enzalutamide, Abiraterone
- Cytarabine ARA-C
- Methotrexate
- Atezolizumab
- Lamivudine
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Polyethylene glycol 3350
- PF-00868554
- SERETIDE Diskus
- Ruxolitinib
- Flibanserin 100 mg dose every evening
- Bortezomib/dexamethasone
- Oxycodone, fentanyl
- Indoximod
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Benin
- Contract Research Organizations in Canada
- Contract Research Organizations in Congo
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Georgia
- Contract Research Organizations in Hungary
- Contract Research Organizations in Ireland
- Contract Research Organizations in Mali
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Portugal
- Contract Research Organizations in Togo
- Contract Research Organizations in Zimbabwe
- CRO list by country